JPSIM Journal of Pakistan Society of Internal Medicine J Pak Soc Intern Med 2709-8729 2710-0804 Pakistan Society of Internal Medicine 10.70302/jpsim.v4i1.2311 jpsim.v4i1.2311 Original Research Chronic Obstructive Pulmonary Disease in Patients Presenting with Heart Failure Siddiqa Ayesha ashu_maz@yahoo.com * Ibrahim Hussain Haadia Latif Sobia Zareen Scouts Medical Complex Gilgit Medical Specialist UK Cardiology Hospital Quetta CMH Rawalpindi Avecina Hospital Lahore *Correspondence: Ayesha Siddiqa (ashu_maz@yahoo.com) 13 02 2023 2023 4 1 51 55 09 11 2022 12 12 2022 Copyright © 2023 The Author(s) 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective

To determine the frequency of chronic obstructive pulmonary disease in patients presenting with Congestive Heart Failure.

 Methodology

This cross sectional study was undertaken in Department of Internal Medicine, Combined Military Hospital, Lahore, from September 2015 to March 2016. 100 cases fulfilling inclusion criteria were enrolled in study through purposive sampling technique. Pulmonary function test was performed in patients by using spirometry to measure their forced vital capacity (FVC), forced expiratory volume in the first second (FEV1) and FVC to FEV1 ratio. If the levels of spirometry assessment were low, then the patient was labeled as having poor pulmonary function. All the data was entered and analyzed utilizing SPSS version 26.

 Results

In this study, the mean age of the patients was 60.31±11.08 years. There were 64(64.0%) males and 36(36.0%) females. The male to female ratio was 1.7:1. The mean values of FVC, FEV1, and FVC/FEV1 ratio of the patients were 80.30±7.26, 59.75±5.99, and 0.75±0.102, respectively. The COPD was observed in 33(33%) patients with CHF. There was no statistically significant difference between the age group and gender with COPD (p>0.05).

 Conclusion

The prevalence of COPD is substantial in patients admitted with CHF (33.0%). Therefore, spirometry ought to be done earlier in CHF patients to timely diagnose COPD, if present. So that early and appropriate therapeutic strategies can be planned to improve the prognosis and quality of life in such patients.

 Keywords Chronic Obstructive Pulmonary Disease Spirometry Congestive Heart Failure Forced expiratory volume in the first second Forced Vital Capacity. References Hugo MNB, Lum CV, Ebenezer AT, Anastase D, Roger N, Felicité K, et al. Chronic obstructive pulmonary disease in patients with stable heart failure: Prevalence and associated factors. Arch Pumlnol Resp Care. 2020;6(1):090-5. Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-56. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart disease and stroke statistics—2021 update: a report from the American Heart Association. Circulation. 2021;143(8):e254-e743. Roger VL. Epidemiology of heart failure: a contemporary perspective. Circ Res. 2021;128(10):1421-34. Noor L, Adnan Y, Khan SB, Shah SS, Sawar S, Qadoos A, et al. Inpatient burden of heart failure in the cardiology units of tertiary care hospitals in Peshawar. Pak J Physiol. 2012;8(1):3-6. Hurst JR, Skolnik N, Hansen GJ, Anzueto A, Donaldson GC, Dransfield MT, et al. Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life. Eur J Intern Med. 2020;73:1-6. Adeloye D, Song P, Zhu Y, Campbell H, Sheikh A, Rudan I, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis. Lancet Resp Med. 2022;10(5):447-58. Khan MA, Khan MA, Walley JD, Khan N, Sheikh FI, Ali S, et al. Feasibility of delivering integrated COPD-asthma care at primary and secondary level public healthcare facilities in Pakistan: a process evaluation. BJGP Open. 2019;3(1):1-12. Tollånes MC, Sjaastad GE, Aarli BB, Sandberg S. Spirometry in chronic obstructive pulmonary disease in Norwegian general practice. BMC Fam Prac. 2020;21(1):1-6. Hawkins NM, Virani S, Ceconi C. Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services. Eur Heart J. 2013;34(36):2795-807. Boschetto P, Fucili A, Stendardo M, Malagu M, Parrinello G, Casimirri E, et al. Occurrence and impact of chronic obstructive pulmonary disease in elderly patients with stable heart failure. Respirology. 2013;18(1):125-30. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130-9. Ostojić J, Pintarić H. Chronic obstructive pulmonary disease and heart failure: closer than close. Acta Clin Croat. 2017;56(2):269-76. Griffo R, Spanevello A, Temporelli PL, Faggiano P, Carone M, Magni G, et al. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey. Eur J Prev Cardiol. 2017;24(6):567-76. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, et al. Importance of heart failure with preserved systolic function in patients≥ 65 years of age. Am J Cardiol. 2001;87(4):413-9. Cuthbert JJ, Kearsley JW, Kazmi S, Kallvikbakka-Bennett A, Weston J, Davis J, et al. The impact of heart failure and chronic obstructive pulmonary disease on mortality in patients presenting with breathlessness. Clin Res Cardiol. 2019;108(2):185-93. Kitzman DW, Gardin JM, Gottdiener JS, Arnold A, Boineau R, Aurigemma G, et al. Importance of heart failure with preserved systolic function in patients≥ 65 years of age. The American journal of cardiology. 2001;87(4):413-9. Minasian AG, van den Elshout FJ, Dekhuijzen PR, Vos PJ, Willems FF, van den Bergh PJ, et al. Serial pulmonary function tests to diagnose COPD in chronic heart failure. Translational respiratory medicine. 2014;2(1):12. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project. American heart journal. 2002;143(3):412-7. Dahlström U. Frequent non‐cardiac comorbidities in patients with chronic heart failure. European journal of heart failure. 2005;7(3):309-16. Mascarenhas J, Lourenço P, Lopes R, Azevedo A, Bettencourt P. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications. American heart journal. 2008;155(3):521-5. Recio-Iglesias J, Grau-Amorós J, Formiga F, Camafort-Babkowski M, Trullàs-Vila J, Rodriguez A. [Chronic obstructive pulmonary disease on inpatients with heart failure. GESAIC study results]. Medicina clinica. 2010;134(10):427-32. Lainscak M, Hodoscek LM, Düngen H-D, Rauchhaus M, Doehner W, Anker SD, et al. The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure. Wiener klinische Wochenschrift. 2009;121(9-10):309-13. Valk MJ, Broekhuizen BD, Mosterd A, Zuithoff NP, Hoes AW, Rutten FH. COPD in patients with stable heart failure in the primary care setting. Int J Chronic Obstr Pulmonol Dis. 2015;10:1219-24. Iversen K, Kjaergaard J, Akkan D, Kober L, Torp‐Pedersen C, Hassager C, et al. Chronic obstructive pulmonary disease in patients admitted with heart failure. J Intern Med. 2008;264(4):361-9. Brenner S, Güder G, Berliner D, Deubner N, Fröhlich K, Ertl G, et al. Airway obstruction in systolic heart failure–COPD or congestion? International journal of cardiology. 2013;168(3):1910-6. Apostolovic S, Jankovic-Tomasevic R, Salinger-Martinovic S, Djordjevic-Radojkovic D, Stanojevic D, Pavlovic M, et al. Frequency and significance of unrecognized chronic obstructive pulmonary disease in elderly patients with stable heart failure. Aging Clin Exp Res. 2011;23(5):337-42.